NVNO

enVVeno Medical Corporation

4.81 USD
+0.15 (+3.22%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

enVVeno Medical Corporation stock is down -2.83% since 30 days ago. The next earnings date is Jul 29, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 6 June’s closed higher than May.

About enVVeno Medical Corporation

enVVeno Medical Corporation focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the. treatment of severe deep venous chronic venous insufficiency.